Paper3680293
Structural characterization of natural human urinary and recombinant DNA-derived erythropoietin. Identification of des-arginine 166 erythropoietin.
Recny MA and 2 others. J Biol Chem, 1987. Cited by 158 papers, by iCite.
Cite this record
ConductScience Library. Structural characterization of natural human urinary and recombinant DNA-derived erythropoietin. Identification of des-arginine 166 erythropoietin. Papers, record 3680293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3680293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Structural characterization of natural human urinary and recombinant DNA-derived erythropoietin. Identification of des-arginine 166 erythropoietin.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA, Recombinant | Major topic |
| Erythropoietin | Major topic |
| Peptide Fragments | Major topic |
| Amino Acid Sequence | |
| Amino Acids | |
| Humans | |
| Mass Spectrometry | |
| Peptide Mapping |
Source PubMed
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 158 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37631301 | Satisfying QTPP of Erythropoietin Biosimilar by QbD through DoE-Derived Downstream Process Engineering. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37631301 | PubMed |
| 37111367 | Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37111367 | PubMed |
| 36557993 | Impact of N-Linked Glycosylation on Therapeutic Proteins. | Molecules | 2022 | https://conductscience.org/library/papers/36557993 | PubMed |
| 35292912 | A Reference Standard for Analytical Testing of Erythropoietin. | Pharm Res | 2022 | https://conductscience.org/library/papers/35292912 | PubMed |
| 35250554 | The Effect of Erythropoietin and Its Derivatives on Ischemic Stroke Therapy: A Comprehensive Review. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35250554 | PubMed |
| 34681039 | Signaling Pathways That Regulate Normal and Aberrant Red Blood Cell Development. | Genes (Basel) | 2021 | https://conductscience.org/library/papers/34681039 | PubMed |
| 32271992 | Temperature Down-Shift Modifies Expression of UPR-/ERAD-Related Genes and Enhances Production of a Chimeric Fusion Protein in CHO Cells. | Biotechnol J | 2021 | https://conductscience.org/library/papers/32271992 | PubMed |
| 32038269 | The Many Facets of Erythropoietin Physiologic and Metabolic Response. | Front Physiol | 2019 | https://conductscience.org/library/papers/32038269 | PubMed |
| 30774876 | A synthetic approach to 'click' neoglycoprotein analogues of EPO employing one-pot native chemical ligation and CuAAC chemistry. | Chem Sci | 2019 | https://conductscience.org/library/papers/30774876 | PubMed |
| 28987867 | Neuroprotective effect of a new variant of Epo nonhematopoietic against oxidative stress. | Redox Biol | 2018 | https://conductscience.org/library/papers/28987867 | PubMed |
| 25784818 | Epoetin beta for the treatment of chemotherapy-induced anemia: an update. | Onco Targets Ther | 2015 | https://conductscience.org/library/papers/25784818 | PubMed |
| 25504272 | C-Terminally fused affinity Strep-tag II is removed by proteolysis from recombinant human erythropoietin expressed in transgenic tobacco plants. | Plant Cell Rep | 2015 | https://conductscience.org/library/papers/25504272 | PubMed |
| 25426117 | Erythropoietin and cancer: the unintended consequences of anemia correction. | Front Immunol | 2014 | https://conductscience.org/library/papers/25426117 | PubMed |
| 24918289 | Erythropoietin action in stress response, tissue maintenance and metabolism. | Int J Mol Sci | 2014 | https://conductscience.org/library/papers/24918289 | PubMed |
| 24337294 | Erythropoietin derived by chemical synthesis. | Science | 2013 | https://conductscience.org/library/papers/24337294 | PubMed |
| 23912564 | Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents. | Clin Pharmacokinet | 2013 | https://conductscience.org/library/papers/23912564 | PubMed |
| 23372778 | Generation of biologically active multi-sialylated recombinant human EPOFc in plants. | PLoS One | 2013 | https://conductscience.org/library/papers/23372778 | PubMed |
| 23216370 | Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit. | Br J Clin Pharmacol | 2013 | https://conductscience.org/library/papers/23216370 | PubMed |
| 22499784 | Probing the stability of nonglycosylated wild-type erythropoietin protein via reiterative alanine ligations. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22499784 | PubMed |
| 22358640 | Erythropoietin processing in erythropoietic system and central nervous system. | Cytotechnology | 1995 | https://conductscience.org/library/papers/22358640 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| EPO | 2056 | PubTator's text mining | https://conductscience.org/library/genes/2056 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3680293
GET https://conductscience.org/api/papers/v1/3680293/cited_by?page=2